Maltofer - IV 1gm Injection

✔️ Uses of Maltofer-IV 1gm Injection

• Treatment of Iron Deficiency Anemia

✔️ How to use Maltofer-IV 1gm Injection

Your doctor or nurse will give you this medicine. Kindly do not self-administer.

✔️ How Maltofer-IV 1gm Injection works

Maltofer is an anti-anemic medication. It replenishes the iron stores in your body. Iron is vital for the formation of new red blood cells and hemoglobin, a substance that gives these cells the ability to transport oxygen.

✔️ What if you forget to take Maltofer-IV 500 Injection?

If you miss a dose of Maltofer, please consult your doctor.

✔️ Quick Suggestions:

• Maltofer-IV 1gm Injection is used for the treatment of iron deficiency when oral iron preparations are ineffective or cannot be used.
• Your doctor or nurse will administer it by injection. You will be observed for at least 30 minutes after each injection as it may cause an allergic reaction.
• Your blood pressure and blood iron levels will be regularly monitored during treatment with this medication.
• Inform your doctor if you are taking any iron-containing products by mouth.
• It may cause your stools to become black or dark in color. This is normal and harmless.

✔️ Side Effects of Maltofer-IV 1gmInjection

• Nausea
• Flushing
• Dizziness
• High blood pressure
• Low levels of phosphorus in the blood
• Injection site reactions

✔️ Indications of Maltofer-IV 1gm Injection

Maltofer-IV 1gm Injection is a member of the class of anti-anemic drugs used to treat iron deficiency anemia in patients with chronic renal disease who are non-dialysis dependent, intolerant to oral iron preparations, or who need a rapid buildup of iron reserves. Iron deficiency anemia (lack of red blood cells caused by too little iron in the body) is a condition in which the body does not have enough red blood cells for carrying adequate oxygen to various body tissues.
Maltofer-IV 1gm Injection 20ml contains ‘ferric carboxy maltose, which acts as a source of iron and helps in the transportation of oxygen throughout the body and the production of red blood cells. Thereby, Maltofer-IV 1gm Injection 10ml helps in treating anemia. Maltofer-IV 1gm Injection 20ml helps various vital processes in the body. 

✔️ Pharmacology

Non-dextran IV is a colloidal iron hydroxide complexed with carboxy maltose, a carbohydrate polymer that releases iron. It also replenishes the iron stores in hemoglobin, myoglobin, and enzymes. Hemoglobin aids in the transportation of oxygen. Macrophages consume FCM from blood and control the release of iron. Iron is carried to the liver, spleen, and bone marrow by transferrin, which binds to iron.

✔️ Dosage & Administration of Maltofer-IV 1gm Injection

• Give Ferric Carboxy Maltose in two doses separated by at least seven days for patients weighing 50 kg or more. Each dose should contain 750 mg, with a maximum cumulative dose of 1500 mg per course.
• Ferric Carboxy Maltose dosage is specified in milligrams of elemental iron. 50 mg of elemental iron are present in each mL of ferric carboxy maltose. If iron deficiency anemia reappears, the ferric carboxy maltose treatment can be repeated.
• Use an intravenous infusion or a slow, undiluted intravenous push to administer ferric carboxy maltose. Give at a rate of about 100 mg (2 mL) per minute when given as a slow intravenous push. When given as an infusion, dilute up to 750 mg of iron in a maximum of 250 mL of sterile 0.9% sodium chloride injection, USP, so that the infusion's iron concentration is at least 2 mg per mL. This should be done over a minimum of 15 minutes.
• Ferric Carboxy Maltose Solution is physically and chemically stable for 72 hours when kept at room temperature when added to an infusion bag containing 0.9% Sodium Chloride Injection, USP, at concentrations ranging from 2 mg to 4 mg of iron per mL. Do not dilute to concentrations lower than 2 mg iron/mL in order to maintain stability. Ferric Carboxy Maltose Solution is physically and chemically stable for 72 hours when kept at room temperature when added to an infusion bag containing 0.9% Sodium Chloride Injection, USP, at concentrations ranging from 2 mg to 4 mg of iron per mL. Do not dilute to concentrations lower than 2 mg iron/mL in order to maintain stability.
• Prior to administration, visually check parenteral drug products for impurities and discoloration. There are no preservatives in the product. Ferric Carboxy Maltose is only meant for a single use per vial. Following injection, any unused medication must be thrown away.
• Avoid extravasating ferric carboxy Maltose because the extravasation site may develop a permanent brown discoloration. Keep an eye out for invasion. If extravasation happens, stop administering ferric carboxy Maltose there.
• Prior to administration, visually check parenteral drug products for impurities and discoloration. There are no preservatives in the product. Ferric Carboxy Maltose is only meant for a single use per vial. Following injection, any unused medication must be thrown away.
• Avoid extravasation of Ferric Carboxymaltose since brown discoloration of the extravasation site may be long-lasting. Monitor for extravasation. If extravasation occurs, discontinue the Ferric Carboxymaltose administration at that site.

✔️ Interaction of Maltofer-IV 1gm

There are no known or well-documented medication interactions.

✔️ Contraindications

Any of its constituents can cause hypersensitivity.

✔️ Pregnancy & Lactation

Pregnancy Type C. Animal reproduction studies have revealed a detrimental impact on the fetus, and there have been no appropriate and well-controlled human trials, although possible advantages may justify the drug's usage in pregnant women despite potential dangers.

✔️ Precautions & Warnings

• Patients taking ferric Carboxy Maltose have experienced severe hypersensitivity reactions, including anaphylactic-type reactions, some of which have been fatal.
• Patients may experience shock, clinically severe hypotension, unconsciousness, and/or collapse. After receiving ferric carboxy Maltose, patients should continue to be watched for signs and symptoms of hypersensitivity for at least 30 minutes or until they reach a clinically stable state.
• Use ferric Carboxy Maltose only in situations where it is possible to quickly access medical personnel and treatments for severe hypersensitivity reactions.
• In addition to wheezing and hypotension, other acute or severe adverse reactions that can result from hypersensitivity include pruritus, rash, urticaria, and urticaria.
• Transient increases in systolic blood pressure were reported, occasionally accompanied by face flushing, dizziness, or nausea.
• These increases were often observed shortly upon dosage and disappeared within 30 minutes.
• Following each Ferric Carboxy Maltose dose, check patients for signs and symptoms of hypertension.
• Regular monitoring of blood pressure and phosphorus levels whilst on treatment with Maltofer-IV 500 Injection 10ml is advised.
• Maltofer-IV 1gm Injection 20ml might cause blackening/darkening of the stools and can interfere with test results. Inform the person doing the tests that you are taking Maltofer-IV 1gm Injection 10ml if you are having tests on your stools.
• Regular blood tests while taking Maltofer-IV 1gm injection 10ml are advised.

✔️ Storage Condition

Ferium Injection vials should be stored at 20°C to 25°C (68°F to 77°F). Remember, these should not be frozen. The temperature should not deviate more than 15°C to 30°C (59°F to 86°F).